A B S T R A C T Rhesus monkeys with airway responses to aerosol challenge with Ascaris antigen constitute a primate model of inhalant asthma. Previous studies have shown that bronchial lavage cells from airway-reactive animals will release histamine or a slow-reactive substance of anaphylaxis after challenge with antigen.
Because these bronchial lumen cells are the first cells in contact with inhaled antigen, they may play a role in induction of antigen-induced airway responses. To evaluate this possibility, bronchial lumen lavage cells from animals with airway reactivity were transferred to the bronchial lumens of animals with negative airway responses to antigen challenge. The transfer of the bronchial lumen cells resulted in transient airway reactivity of the recipients to aerosol antigen challenge. It is suggested that the mast cells which constitute a component of the bronchial lumen cells may be the active cell alone, or in combination with other cells, which results in this primate immunoglobulin Emediated airway response and its transfer to nonreactive recipients.
INTRODUCTION
The experiments to be described resulted from the following series of observations. In studies of the cellular composition of bronchial lavage fluid, it was observed that a small percentage (0.5-1%) of these cells had morphologic characteristics of mast cells, basophils, or both (1) . Studies of these bronchial lumen mast cells (BLMC)l demonstrated that similar cells were present in the bronchi of rhesus monkeys, dogs (1) , and humans (2) . The cells have been shown to be alive by their staining characteristics and ability to release histamine to immunologic stimuli (1, 3) . When lavage cells are obtained from the bronchial lumens of rhesus monkeys with immunoglobulin E-(IgE-) mediated respiratory responses, the cells release histamine and a slow-reacting substance of anaphylaxis to appropriate antigenic stimuli (3) . Although the mast cells could be identified with ease by routine microscopy, their exact classification was uncertain until appropriate electronmicroscopic studies were performed. These studies defined the bronchial lumen cells from humans as mast cells (4) . The presence of living mast cells in the bronchi provides a source of respiratory mast cells for study which can be obtained by noninvasive techniques. A general question regarding bronchial lumen cells is whether, as free cells in the airway in first contact with inhaled antigen, they are capable of stimulating an antigen-induced airway response in the allergic animal. The answer to this question appeared to require the transfer of antigen-induced airway responses to a recipient animal with bronchial lumen cells of a reactive animal. In planning an experimental approach to achieve transfer, there appeared to be several complexities and potential problems. These included: (a) the requirement of a sufficient ntumber of bronchial lumen cells (BLC) from highly reactive donors, (b) that these cells be distributed appropriately to the airway of recipient animals, and (c) the use of an appropriate recipient animal. We have previously demonstrated that all rhesus monkeys with significant degrees of cutaneous reactivity to antigen do not have airway responses to aerosolized-antigen, and that animals with consistent airway reactivity to antigen have hyperreactive airways to analogues of acetylcholine similar to the human asthmatic (5) . With these problems in mind, we developed test systems and report experiments which show that BLC from rhesus monkeys with airway reactivity to ascaris antigen will transfer this airway reactivity to recipient animals. The pos-sibility that the BLMC are the major cellular component that transfer airway reactivity cannot be proven, but deserves considlerationi anid further study.
METHODS
Atnimczals. Animals are young adult male and female Macaca mulatta which weigh from 2.5 to 11.5 kg. Selection and screening of animals has been described in detail (5) . All BLC donors with positive respiratory responses to aerosol challenge with ascaris antigen, had a positive response defined as previously reported (5) .
Antigens and antisera. Ascaris antigen (Asc.) was obtained by sequential Sephadex (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) G-50 and G-75-column fractionation of Ascaris suum extract by the method of Hogarth-Scott (6 (9) . The following parameters of respiration were recorded: breathing frequency (BF), peak expiratory flow rate (PEFR), expiratoryinspiratory time period (E/I), tidal volume (TV), pulmonary resistance (PR), and dynamic compliance (Cdyn.). The PEFR is the maximal expiratory flow during quiet (nonforced) ex- The C dyn. is the ratio between TV and the change in P from the start to the end of inspirationi (flow = 0).
The computation of PR and C dyn. for each respiratory cycle was performed by an on-line analog computer (Respiratory Mechanics Comiiputer; Buxco Electronics, Inc., Sharon, Conn.) which generates a signal proportional to the PR and C dyn.
The flow, P, TV, PR, and C dyn. signals were recorded simultaneously on a Brush Mark 260 recorder (Gould, Inc., Systems Div., Cleveland, Ohio). All parameters were determined from this tracing by averaging 10 respiratory cycles.
Next, the absolute base-line PF values of the controls for each PF parameter were compared with the absolute values after PBS aerosol in animals either receiving BLC and or in animals not receiving BLC. The Student's t test was used to evaluate these comparisons. The base-line PF values before antigen challenge were used to calculate the percent change from base line.
In a series of studies (5, 7, 9, 11) , it has been established that although the absolute base-line PF levels varied between animals (9), these levels did not change significantly (more than 10%) in an animal that had no aerosol challenge, or in any animal challenged by aerosol of PBS. Atropine did not result in more than that percentage of variation from the base line. Because of this, the most useful system for analysis of the respiratory response was found to be the comparison of post challenge results with each agonist and those obtained during the control period after the PBS challenge, with expression of the results as percent-change from the base line control period. The minimal criteria for positive responses of individual parameters are: BF, +20%, E/I, +25%; PR, +25%; TV, -15%; C dyn., -20%; and PEFR, -25%. These criteria represent mean±2 SD. Five of the six parameters must meet the above criteria to be considered a positive response.
Determination of Hist. aerosol threshold. The same monkeys used as recipients for respiratory cells (RC) were challenged by Hist. as an aerosol with concentrations of 6, 60, 600, and 6,000,ug/ml.
Cutaneous reactivity to Asc. Preparations of Asc. were tested in anesthetized monkeys that had received 5 ml of 0.5% Evans' Blue Dye (Warner-Lambert Pharmaceutical Co., Morris Plains, N. J.). Serial 10-fold dilutions of Asc. were used. Positive reactions were deep blue areas at least 10 x 10 mm in diameter and negative reactions had no bluing.
Brontchial lavage. For each transfer experiment, three monkeys reactive to Asc. (Table I) were anesthetized with intraperitoneal pentobarbital. 60 ml of Ringer's-lactate solution was introduced into the tracheobronchial tree by means of a catheter inserted through an endotracheal tube. The Ringer's-lactate solution was aspirated and prepared for cell counts and transfer to recipient animals. Recovered bronchial lavage fluids from each of the three donor monkeys was centrifuged at 500 g for 10 min at 4°C. The supernate was removed and 3 ml of tissue culture medium (Medium 199 with Hanks' balanced salt solution, Grand Island Biological Co., Grand Island, N. Y.) was added to each cell pellet. The pellets were suspended and combined and the vol was brought to 10 ml. Cell counts were performed in a hemocytometer chamber. Cells were washed and centrifuged one more time at 500 g for 10 min at 4°C. The supernate was decanted, 10 ml of tissue culture medium was added and the donor cells resuspended to deliver to recipient.
Cell transfer experiments. Recipient monkeys were anesthetized with pentobarbital and donor cells were introduced through a catheter inserted through the endotracheal tube. Donor cells were suspended in 10 ml of tissue culture medium. After injection of cells through the endotracheal tube, the recipient animals were vigorously rotated in an attempt to distribute cells into the bronchi. The animals immediately received a control aerosol challenge with PBS Table I ). The results of an experiment with a different monkey as an RC recipient are shown in Fig. 2 . The control challenge with Asc. (pre-RC transfer) is negative (Fig.  2a) , but after RC transfer aerosol challenge with Asc. is followed by a positive respiratory response (Fig. 2b) . The, results of these two experiments and four additional experiments are summarized in Table III . These results show positive-airway responses to Asc. challenge after RC transfer to the recipients in five of six experiments. One of these recipients had only a 0.1 titer by skin test to Asc. and had never had a positive airway response to Asc. The supernatant solutions from bronchial lavage cells were used for separate experiments. Cell supernates from three cell preparations which had successfully transferred bronchial reactivity were transferred to the bronchial lumens of non-Asc.-reactive recipients. The recipient animals were then immediately challenged with Asc. in a manner identical to that after bronchial cell transfer. In three such experiments no respiratory responses occurred, which demonstrates that the cell supernate did not transfer reactivity under the conditions of the experiments. Although IgE antibody was likely present in the bronchial cell wash fluid, the short incubation interval (10 min) was not sufficient for passive cell sensitization.
BLC from nonreactive donors were transferred to the same nonreactive recipients used in initial, successful transfer experiments. The recipients of cells were then (Table IV) . Hist. release from these RC, due to Asc. antigen, could be detected (Fig. 3) but was of minimal magnitude.
Aerosol Hist. thresholds of recipient animals. Rhesus monkeys used as recipients for BLC transfer (Table I and III) received aerosol challenges with increasing concentrations of Hist. (6, 60 , 600, and 6,000 ,ug/ml). The concentration of Hist. that produces PF changes characteristic of the antigen-induced response ( Figs. 1 and 2 ) was determined. These thresholds for monkeys 6, 7, and 8 (Tables I and III) were 6,000 ,ug/ ml for all three monkeys.
DISCUSSION
These results demonstrate (a) that airway reactions to antigen can be transferred by RC obtained from bronchial lumens of donor animals with IgE-mediated airway responses and (b) that cells within the bronchial lumen can initiate the airway response after immunologic stimulation. The latter observation may be of considerable significance because the mast cell, possibly Table III. t Combined cells obtained from bronchial lavage ofthree Asc.
reactive donor animals (see Table I ). Tables III and IV. responsible, has been identified in three species: man, monkey, and dog. The cells from the bronchial lumen used in these experiments which transfer reactivity have not been identified. It is possible or even probable that mast cells are involved. The Asc.-sensitive rhesus monkeys have reactivity consistent with IgE-mediated reactivity (16) . Aerosolized anti-human IgE will produce an identical airway response as Asc. antigen (17) . In monkeys, IgE fixes only to mast cells and basophils (18) . This combination of indirect evidence indicates that mast cells may likely be major participants in the BLC which transfer the airway reactivity.
Comparison of the RC transfer studies which iniclude
Transfer of Airway Reactiotns to Brotnchial Lu meni Cells the analysis of the total amount of Hist. in cells transferred (Table III) We conclude from these studies that respiratory lumen cells, which can transfer bronchial reactivity to unreactive animals, must now be considered as a major potential effector cell in IgE-mediated airway responses and possibly as participants in toxic, infectious, and non-IgE-mediated immunologic airway reactions in which mast cells may participate.
